Introduction
============

In systemic inflammation and sepsis, the endo-cannabinoid system is upregulated \[[@B1]\]. While it is known that neuronal cannabinoid signalling via cannabinoid receptor-1 (CB1) in the central nervous system represents an intrinsic neuroprotective response \[[@B2]\] and exerts anti-epileptic activity \[[@B3]\], inhibition of CB1 (CB1inh) has been suggested as an experimental target for sepsis therapy \[[@B4]\]. We studied the effects of CB1inh in rats with experimental sepsis during anesthesia induction with pentobarbital.

Methods
=======

Five groups of Lewis rats were included in the study: Group 1 - sham-operated controls treated with CB1inh (AM281, 2.5 mg/kg i.v., *n*= 12), Group 2 - animals with colon ascendens stent peritonitis (CASP)-induced sepsis treated with CB1inh (*n*= 12). As additional control groups we administered in CASP animals the CB1 agonist ACEA (2.5 mg/kg i.v.; Group 3; *n*= 4) or the solvent DMSO (Group 4; *n*= 4). In Group 5 we administered 50 mg/kg ketamine for induction of anesthesia 14 hours following the CASP treated by CB1inh. All other groups received a standard dose of pentobarbital (40 mg/kg i.v.) 14 hours following CASP procedure.

Results
=======

In five out of 12 septic animals (42%) with CB1inh (Group 2) we observed tonic-clonic seizures immediately after induction of anesthesia with a standard dose of pentobarbital. In sham-operated animals (Group 1) or CASP animals without CB1inh (Group 4) we did not observe anesthetic-induced excitation. Replacement of the barbiturate by ketamine (Group 5) avoided seizures as well as treatment with the CB1 agonist (Group 3).

Conclusions
===========

CB1 inhibition in sepsis may increase the incidence of anesthetic-induced excitation and reduce CB1-mediated intrinsic neuroprotective response.
